ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s ...
Health tech startup Dandelion Health launched a clinical artificial intelligence marketplace that merges third-party algorithms and Dandelion's data platform and model validation capabilities to ...
Investigators who designed a base-editing treatment are planning an "umbrella of umbrellas" trial, while others are developing roadmaps to guide personalized treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback